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BACKGROUND
Chronic low back pain is a major public health and economic problem leading to billions of dollars in health care expenditure 1 in the United States. Chronic low back pain has been estimated to be discogenic in origin 40% of the time. 2, 3 Currently, provocative lumbar discography is the most sensitive and specific tool for diagnosis of lumbar discogenic pain, 4 although controversies exist. 5 Discogenic low back pain is not well correlated with intervertebral disc (IVD) degeneration: most individuals with disc degeneration are not affected by chronic symptoms. 6 The individuals who are affected by chronic, debilitating spinal pain due to symptomatic degenerative disc disease usually begin to suffer during their early adult years and rarely achieve complete relief from the available medical therapies. Current surgical treatments for severely symptomatic disc degeneration are limited to procedures that disrupt, rather than restore, the disc structure (eg, spinal fusion or disc arthroplasty). Furthermore, the degree of symptomatic relief after surgery is unpredictable and often incomplete, mainly because the exact cause of pain is poorly understood. Degenerative disc disease may be responsive to biologic therapies 7 ; whether restoring disc structure will reduce back pain is unclear, however.
Kang et al. 8 have reported increased cytokine production in herniated disc tissues. However, axial discogenic pain is different in character from radicular pain resulting from disc herniation and is less responsive to current treatments. In this study, we aimed to identify biological markers that differentiate painful degenerative discs and asymptomatic discs with matching degrees of degeneration to understand why morphologically similar discs can show marked differences in clinical symptoms. 6 Cytokines that differentiate pain-generating IVDs from similar-appearing degenerative IVDs that are not major sources of pain might help to predict treatment outcomes and serve as targets for biological therapies.
The source of cytokines in IVDs has been debatable. In herniated IVDs, inflammatory cells infiltrate the disc tissues and may produce cytokines. In this study, we aimed to demonstrate that cultured IVD cells are fully capable of secreting inflammatory mediators.
MATERIALS AND METHODS Cytokine Gene Expression and Protein Production by Cultured Cells from Cadaveric Donors Tissue Collection
Intervertebral discs were obtained from human spine segments (donor age range, 21Y75 years) procured by the Gift of Hope Human Donor and Tissue Network of Illinois (approved by the institutional review board [IRB]; ORA No. L01012604). Intervertebral discs were dissected within 24 hours from time of death, immediately after the spine segments were transported to the laboratory. Annulus fibrosus and NP were separated. Cells were released by 0.4% Pronase (Calbiochem/Millipore) for 1 hour followed by 0.025% collagenase-P (Boehringer Ingelheim) digestion overnight. Cells were then plated in monolayer at 4 Â 10 4 cells/cm 2 in 12-well plates (Corning Life Sciences) with 1 mL/well of Dulbecco_s modified Eagle medium/nutrient mixture F-12 (DMEM/F12) medium with 20% fetal bovine serum until confluent. Cells were then serum-starved for 24 hours and then stimulated with IL-1A (10 ng/mL; R&D systems, MN) in serum-free media for 24 hours. IL-8, IL-7, and IL-10 gene expression was analyzed using real-time polymerase chain reaction (PCR). IL-8 protein in the conditioned media was quantified using enzyme-linked immunosorbent assay (ELISA) (Invitrogen, CA).
Real-Time PCR
RNA from cultured NP and AF cells was isolated using an RNeasy Kit (Qiagen). Total RNA (0.5Y1.0 Kg) was reverse transcribed into complementary DNA with random primers using a high-capacity RNA to cDNA kit (Applied Biosystems). The expression levels of IL-8, IL-7, and IL-10 were determined with realtime PCR using Taqman Gene Expression Assays (Applied Biosystems). Amplification was performed
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with Taqman PCR Master Mix (Applied Biosystems) and a spectrofluorometric thermal cycler (7300 Realtime PCR System, Applied Biosystems). To standardize messenger RNA levels, the GAPDH gene was used as an internal control.
Enzyme-linked Immunosorbent Assay
Conditioned media from cultured NP and AF cells were collected and stored at j80-C until assayed. IL-8 was quantified using the Human IL-8 CytoSet ELISA kit (Invitrogen) according to the manufacturer_s instructions.
Cytokine Protein Content in Patient-Derived Tissues by Cytokine Array Patient Selection and Tissue Preparation
Lumbar IVD tissues were collected from patients undergoing spinal surgery at Thomas Jefferson University Hospital under an IRB-approved protocol (IRB Control No. 05U.237), with written informed consent. This study included adult patients undergoing anterior lumbar interbody fusion surgery for discogenic pain or spinal deformity reconstruction. Larger and less fragmented IVD tissue can be isolated with anterior lumbar fusion surgery compared with the posterior approach. All discs in the painful group were evaluated with provocative discography before surgery ( Figs. 1A, B ). Specifically, discography was performed on patients under conscious sedation, with a double needle technique. A 25G needle was introduced into the central region of the disc (confirmed on anteroposterior and lateral fluoroscopy; Fig. 1 ); 0.5 mL of contrast solution was injected into the disc, and the patient_s objective response (grimace, wince, etc.) was recorded. The patients were asked for an immediate grading of the pain (0/10 to 10/10 scale) and whether the pain was concordant (identical to the clinical pain) or discordant (different from the clinical symptoms). Discography was graded as Bpositive[ when the pain was 8/10 to 10/10 and concordant to axial symptoms according to the patient, Bindeterminate,[ when the pain was 4/10 to 7/10 and concordant to clinical symptoms, and Bnegative,[ when pain was discordant to clinical symptoms. The morphology of the contrast flow on fluoroscopy was noted and recorded. For a disc level to be considered positive, the discographer also had to confirm annular disruption by the fluoroscopic contrast pattern at the painful level, and the presence of a negative level within the lumbar spine of the same patient. Indeterminate or negative discs were excluded from the study. Lumbar discs were also obtained from patients undergoing anterior lumbar fusion for scoliosis (as controls). Patients with scoliosis undergoing deformity correction surgeries have been selected as negative controls, since these patients have degenerative IVDs but back pain is not the primary reason for operation. This allows matching of tissues from discogenic back pain with controls of similar degeneration on magnetic resonance imaging (MRI). However, we acknowledge the limitation of this approach, since patients with scoliosis often have low back pain. Patients with discitis, systemic infection, or systemic inflammatory diseases were excluded from the study. Each study subject was evaluated with MR scanning of the lumbar spine. All studied discs were graded by T2-weighted MRIs using the Pfirrmann grading scheme. 9 Every effort was made to select patients with comparable degrees of IVD degeneration for the painful and control groups to reduce disc degeneration as a major confounding factor ( Table 1) . Patients_ age and sex were also noted ( Table 1) . Patients undergoing discography are under conscious sedation, typically provided by midazolam injection to cause drowsiness, relieve anxiety, and prevent any memory of the event. This medication is Interleukins Found in Patients with Back Pain not known to affect local tissue inflammation and is thus unlikely to affect the biomarkers in the IVD tissue collected after surgery.
The AF were isolated and snap frozen in liquid nitrogen and then stored in a j80-C freezer. Protein concentration was determined by bicinchoninic acid assay (Pierce). Quality of extracted proteins was verified by separation on a 4% to 12% polyacrylamide gel and staining with Coomassie blue. One hundred micrograms of protein was used for each cytokine array.
Cytokine Array Analysis
Human Cytokine Array 3.1 (RayBiotec, Norcross, GA), which detects 42 cytokines simultaneously, was used. The array 3.1 uses the sandwich immunoassay principle, wherein a panel of capture antibodies is immobilized on a nitrocellulose membrane solid support. This array includes antibodies recognizing most of the cytokines known to be present in discs or those that affect chondrocyte extracellular matrix metabolism. The membranes were blocked for 30 minutes before incubation with AF tissue lysates from patients who had undergone lumbar spine surgery for discogenic low back pain and for deformity corrections (as controls) at 4-C overnight. Then the array membranes were washed and incubated with biotin-conjugated detection antibodies for 2 hours. After washing, membranes were incubated with horseradish peroxidaseYconjugated streptavidin for 2 hours (RayBiotec). The membranes were washed, and the chemiluminescence was detected using digital imaging system (ImageQuant LAS-400, GE Healthcare). Each density was further normalized to the average of 4 positive controls within the same membrane and represented as % of positive control.
Pathway Analysis for Cytokine Array
A pathway analysis was performed using Ingenuity Pathway Analysis software (Qiagen, Valencia, CA). Specifically, the raw expression values were lognormal transformed, and a baseline transformation to the median of all values was then performed. The cytokines were subsequently filtered by independent sample Student t test (P G 0.1) and fold change (Q1.5). Of the 42 cytokines, only 8 cytokines met these criteria (Fig. 2) . The data from these cytokines were then applied to hierarchical clustering using Pearson-centered distance metric. Comparison between the painful and control groups was performed with 2-sample unpooled t test for unequal variances (also known as the Welch t test). with 10 ng/mL of IL-1A for 24 hours (Fig. 3A) . Similarly, IL-8 gene expression increased 22,429 fold in AF cells (n = 4; P = 0.0105; Fig. 3B ). IL-8 protein concentration in the culture media also increased in response to IL-1A stimulation (Figs. 3C, D). Nucleus pulposus cells secreted an average of 31 pg/mL of IL-8 into the culture media in the absence of IL-1A (n = 4). The IL-8 concentration increased to 74,056 pg/mL after incubation with IL-1A for 24 hours (n = 4). This represents a 2,389-fold increase (n = 4; P = 0.0055; Fig. 3C ). Additionally, IL-8 protein secreted by the AF cells into the culture media increased from an average of 53 pg/mL to 94,540 pg/mL in response to IL-1A treatment. This represents a 1,784-fold increase (n = 4; P = 0.0532; Fig. 3D ).
RESULTS

IL-8 Gene Expression and Protein Secretion Were Upregulated by IL-1A Treatment in Cultured Primary Human NP and AF Cells
Expression of IL-7 and IL-10 Genes Was Induced by IL-1A
Interestingly, gene expression for IL-7 (known as a hematopoietic growth factor) in NP cells also showed a moderate increase in response to IL-1A stimulation (3.28-fold increase, n = 4; P = 0.0145; Fig. 4A ). IL-7 gene expression did not increase significantly in AF cells after IL-1A stimulation (4.35-fold of control, n = 4; P = 0.0760; Fig. 4B ). IL-10 gene expression also showed a trend to increase after IL-1A stimulation in both NP and AF cells; but owing to the large individual variation, this was not statistically significant (NP: 1490-fold induction, n = 4; P = 0.1330; AF: 98-fold induction, n = 4; P = 0.0648; Figs. 4C, D).
Levels of Multiple Cytokine Proteins in AF Tissues from Patients with Discogenic Low Back Pain Were Higher Than in Tissues from Control Patients
Multiple chemokines/cytokines were elevated in AF tissues from patients with discogenic pain, compared with control tissues from patients with comparable degree(s) of degeneration (Fig. 2) . The color coding corresponds to fold changes compared with baseline (median of all values). Only cytokines showing a 1.5-fold or more difference between the painful and control groups are shown. Cytokines are clustered according to known pathways/gene ontology, indicated with the dendrogram on the left. The branches show the degree of similarity between different molecules: the shorter the branch, the more similarity in the ontology of cytokines.
To further illustrate individual variations, IL-8, IL-7, and IL-10 densities of each patient were plotted ( Fig. 5) . IL-8 level in painful discs was 1.81-fold that of controls (P = 0.0513), while IL-7 increased 6.87 fold (P = 0.0241). IL-10 showed a 4.63 fold increase (P = 0.0171; Figs. 2 and 5). 
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Five other factors showed a significant increase in patients with discogenic pain (Fig. 2) : regulated and normal T-cell expressed and secreted, also known as chemokine C-C motif ligand 5, showed a 2.29-fold increase (P = 0.0218). Stem cell factor increased 3.13-fold (P = 0.0142), whereas chemokine stromal-derived factor-1 increased 3.20-fold (P = 0.0217). IL-13 showed a 3.18-fold increase (P = 0.0329), whereas oncostatin M showed a 2.31-fold increase in the painful group compared with the controls (P = 0.0247).
DISCUSSION
This study has demonstrated that cultured IVD cells produced IL-8 and expressed IL-7 and IL-10 genes in this study. Kang et al. 8, 10 have reported cytokines including IL-6 in herniated cervical and lumbar discs, and infiltrating inflammatory cells are thought to be the source of these inflammatory mediators. The current study has shown that contained, nonherniated IVD tissues express multiple cytokines; the origin of these mediators has been debated because the IVD tissues have limited blood supply and access of inflammatory cells to IVDs is limited. Cultured IVD cells have been shown to produce tumor necrosis factor > and IL-1A. 11 Our current and previous 12 studies have demonstrated that IVD cells, isolated in culture, are fully capable of producing a variety of cytokines and chemokines.
In this study, the authors have shown that cultured IVD cells produce large amounts of IL-8 in response to an inflammatory stimulus (eg, IL-1A). IL-8, also known as CXCL8, is a chemokine produced by macrophages and other cell types, including epithelial cells, airway smooth muscle cells, and endothelial cells. 13 There are many receptors on the surface membrane of various cell types capable of binding IL-8; the most frequently studied types are the G-proteinYcoupled serpentine receptors CXCR1 and CXCR2. 14 Expression and affinity for IL-8 differ between the 2 receptors (CXCR1 9 CXCR2). 14 IL-8 is also known to be a potent promoter of angiogenesis 15 and a chemoattractant for neutrophils. 16 In target cells, IL-8 induces a series of physiological responses required for migration and phagocytosis, including increases in intracellular Ca 2+ , exocytosis (eg, histamine release), and the respiratory burst.
This study has shown for the first time that human IVD cells express the IL-7 and IL-10 genes. IL-7 is a hematopoietic growth factor secreted by stromal cells in the bone marrow and thymus. 17 IL-10, also known as human cytokine synthesis inhibitory factor, is an anti-inflammatory cytokine. IL-10 itself can repress proinflammatory responses and limit excessive tissue disruption caused by inflammation, 18 perhaps representing part of the repair mechanism. Intriguingly, elevated levels of IL-8, along with several other chemokines, correlate with acute inflammatory pain after tissue injury. 19 IL-8 was found to be positively associated with pain in patients with fibromyalgia, a chronic pain syndrome refractory to treatments. 20 The role of IL-8 in discogenic back pain was explored by Burke et al. 21 They showed increased IL-8 and IL-6 production by cultured lumbar IVD explants from patients with discogenic pain compared with patients with sciatica. 21 Consistent with their findings, the authors of this study have shown that IL-8 gene expression and protein production by cultured primary human IVD cells increased by a thousand fold or more after exposure to IL1A. Based on the findings of this study, it is hypothesized that a high level of IL-8 and a cluster of additional inflammatory mediators may, at least in part, mediate back pain. Future studies will be conducted to uncover the role of IL-8 in discogenic pain.
This study has shown elevated levels of chemokines, cytokines, and growth factors in AF tissues isolated from patients with discogenic low back pain. This group has previously reported increased regulated and normal T-cell expressed and secreted and IL-1A levels in patients with discogenic low back pain. 22 The current study extends our previous findings to include IL-8, IL7, IL-10, stem cell factor, stromal-derived factor-1, IL-13, and oncostatin M (Fig. 2 ). As seen in other studies using patient samples, this study found a large individual variation among patients in both the painful and control groups (Fig. 5 ). These variations may represent different stages of IVD degeneration, time from onset of disease to surgery, and age/genetics. It is worth noting that patients undergoing surgery for discogenic pain are primarily women (Table 1) , and approximately 10 years younger on average compared with patients undergoing surgery for deformity corrections. Intervertebral disc degeneration is a slowly progressive cascade mediated in part by inflammation. 23, 24 Inflammatory stimulation directly alters the mechanobiology of NP cells 25 and inhibits cell extracellular matrix production. 26, 27 In this study, the authors made every effort to include morphologically similar IVD tissues by selecting similar degrees of degeneration by matching the same MRI grade for the discogenic pain group and the control group (Table 1) to tease out the etiology of pain. Although clinically, the authors have observed that older patients are less likely to have discogenic axial back pain and are more likely to have neurogenic claudication owing to spinal stenosis than are younger individuals, there is not enough power in the current study to confirm this. The average age in the painful group (45.3 years) is, however, lower than that of the control group (53.5 years).
The anatomical basis for the IVD to generate pain is well documented, although there is still debate on whether the end plate or even the vertebral bodies are the main pain generators in the spine. In the normal disc, the NP is devoid of blood supply or nerve fibers, whereas the posterior 1/3 of the AF contains an extensive network of sensory nerve fibers. Pathologic findings, such as increased nerve and blood vessel ingrowth into the disc, have been associated with proteoglycan depletion. 28 The cytokines described in this study may stimulate nerve endings within the IVD, resulting in discogenic pain. These cytokines may also diffuse to nearby tissues and stimulate nerve endings in the adjacent endplate, ligaments, or bone, contributing to the initiation and maintenance of spinal pain syndromes. Thus, these cytokines might serve as targets for future biological therapies to treat patients with discogenic pain. In addition to the IVD, other tissues may be sources of cytokines since biomarkers in serum have recently been observed to correlate to low back pain. 29 In this study, all IVD tissues isolated are from lumbar spine. Thus, our findings are most applicable to low back pain.
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Finally, more research to characterize the role of cytokines in discogenic back pain is needed to assist in developing novel therapies for patients with this ubiquitous disease. As future clinical innovations of intradiscal therapies evolve, including bone morphogenetic protein, stem cells, and other biologic agents, 7 understanding the mechanism of pain may further guide these exciting developments.
